GOSALIA MEENA ALKESH's Insider Trades & SAST Disclosures
GOSALIA MEENA ALKESH's most recent trade in Parmax Pharma Ltd. was a Acquisition of 254,800 Equity Shares done . Disclosure was reported to the exchange on April 19, 2022 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for GOSALIA MEENA ALKESH in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parmax Pharma | GOSALIA MEENA ALKESH | Directors Immediate Relative | Acquisition | 19 Apr 2022 | 254,800 | 424,800 (11.35%) | 6.81% | 0 | 0 | 08 Apr 2022 16 Apr 2022 |
Insider Trading | Equity Shares | Inter-se Transfer |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.